UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003270 |
|---|---|
| Receipt number | R000003950 |
| Scientific Title | Multicenter Phase II study of erlotinib therapy in recurrent or advanced non-small cell lung cancer patients with Epidermal Growth Factor Receptor (EGFR) mutation |
| Date of disclosure of the study information | 2010/03/01 |
| Last modified on | 2016/07/26 13:38:14 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/03/01 09:39:16 | ||
| 2 | Update | 2010/09/08 11:10:23 | Institutions |
|
| 3 | Update | 2011/03/09 11:43:12 | Recruitment status |
|
| 4 | Update | 2011/09/02 13:09:06 | Organization Organization Category of Funding Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
| 5 | Update | 2012/03/12 16:12:19 | Recruitment status |
|
| 6 | Update | 2016/07/26 13:38:14 | Email Name of primary person or sponsor Institute Organization |
